Investors will close out the week today with the economic calendar featuring the consumer sentiment index.

There are no public companies slated to release quarterly earnings reports today, June 11, as earnings season winds down.

In case you missed it, earlier this week we dropped the 411 on meme stocks. We provided some background, what qualifies a stock as a meme stock, and a bunch of other frequently asked questions. So, here is everything you need to know about meme stocks. At Schaeffer's Investment Research, we see major opportunity surrounding meme stocks to be played from an options perspective. More on that, soon!

Looking ahead to next week, investors will be rounding out mid-June with a mix of economic reports and earnings. Plenty of manufacturing data will be highlighted next week, as well as housing. Wednesday will bring announcements from the Federal Reserve and its Chairman, Jerome Powell. Meanwhile, though earnings season has come and gone, there will still be a handful of quarterly reports to unpack, including H & R Block (HRB), Kroger (KR), and Smith & Wesson Brands (SWBI). All economic dates listed here are tentative and subject to change.

The shares of Wells Fargo &Co (NYSE:WFC) have enjoyed a solid run higher in 2021, adding over 50% since the beginning of the year. The security has yet to overtake its pre-pandemic levels, though, and the bank stock has been middling since May, when it ran into pressure at the $48 mark. Today, the equity is off 1.1% at $45.41, though there's reason to believe the financial name could soon break out of its holding pattern. 

Specifically, WFC just came within one standard deviation of its 40-day moving average, after a lengthy stretch above the trendline. There have been four similar signals occurring in the past three years, according to data from Schaeffer's Senior Quantitative Analyst Rocky White. WFC was higher one month after three of these pullbacks, averaging a 7.3% pop. A similar move would put the security back above aforementioned pressure at the $48 mark, for the first time since February 2020.

An unwinding of pessimism in the options pits could push WFC higher. At the moment, the equity's Schaeffer's put/call open interest ratio (SOIR) of 0.91 stands higher than all other readings from the past year. This suggests short-term options traders have rarely been more put-biased. Plus, at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), WFC sports a 50-day put/call volume ratio that stands in the 96th percentile of its annual range. 

A change of tune among the brokerage bunch could also give Wells Fargo stock some upward momentum. While nine analysts covering WFC consider it a "buy" or better, seven still say "hold." 

Rounding out mid-June will be a mix of economic reports and earnings. Plenty of manufacturing data will be highlighted this week, as well as housing. Wednesday will bring announcements from the Federal Reserve and its Chairman, Jerome Powell. Meanwhile, though earnings season has come and gone, there will still be a handful of quarterly reports to unpack, including H & R Block (HRB), Kroger (KR), and Smith & Wesson Brands (SWBI). 

Below is a list of key market events scheduled for the upcoming week. All economic dates listed below are tentative and subject to change.

 The week will start off slow on Monday, June 14, with nothing scheduled.

Things get busy fast on Tuesday, June 15, however, with retail sales, the producer price index (PPI), Empire state manufacturing index, industrial production data, business inventories, and the NAHB home builders' index slated for release. 

Wednesday, June 16 will bring building permits, housing starts, the import price index, and an update from the Federal Reserve and Fed Chair Jerome Powell. 

Finally, Thursday, June 17, the usual initial and continuing jobless claims data are due out, as well as the Philadelphia Fed manufacturing index, and leading economic indicators.

Friday, June 18, there is no economic data to report. 

Moderna Inc (NASDAQ:MRNA) is back in the spotlight today, after the biotech concern asked the U.S. Food and Drug Administration (FDA) to approve the emergency use of its Covid-19 vaccine mRNA in adolescents ages 12 to 17. On May 25, Moderna said its vaccine was 100% effective in a study of adolescents in that age range -- which included more than 3,700 participants -- and saw no new Covid-19 cases observed after two doses of the vaccine. MRNA is responding well to the news, last seen 1.9% higher to trade at $221.48.

The company made headlines earlier this month after applying for full FDA approval for the vaccine, and the security went on to notch a new record high of $227.71 by June 7. Carving out a channel of higher highs all year, the shares' 10-day moving average has moved in to guide the shares higher in recent months. Now up an impressive 108.6% year-to-date, MRNA is on track for its fourth straight weekly win.

Moderna stock is sporting attractively priced premiums at the moment, too. The stock's Schaeffer's Volatility Index (SVI) of 63% stands higher than just 10% of all other readings from the past year. In simpler terms, option players are pricing in low volatility expectations right now.

What’s more, its Schaeffer's Volatility Scorecard (SVS) sits at a relatively high 81 out of a possible 100, indicating that the stock has managed to exceed these volatility expectations over the last 12 months.

The shares of FuelCell Energy Inc (NASDAQ:FCEL) are off 9.8% at $10.17 this morning, dropping on a fiscal second-quarter earnings and revenue miss. The company cited dwindling service agreements and license revenue as factors for the disappointing report, while its operating expenses rose. 

FCEL has seen a dramatic rise and fall this year, surging to a Feb. 10 three-year high of $29.43, before quickly plummeting with pressure from its 30-day moving average. However, the equity looks to have staged a bounce on its 320-day moving average, putting it back above the aforementioned 30-day late in May. Today's drop has FCEL just north of this trendline, still sporting a year-over-year rise of 331.8%. 

Despite this, analysts are bearish on FCEL. Of the seven in coverage, five say "hold," and two say "sell." Meanwhile, the 12-month consensus price target of $11.96 is a 17.7% premium to current levels, which could mean some lowered price targets from the brokerage bunch. 

Short interest has been on the rise, up 24.9% in the last two reporting periods. The 45.46 million shares sold short now make up an incredible 42.2% of the stock's available float, or a little under two days at its average pace of trading.